Is GoodRx Holdings, Inc. overvalued or undervalued?
2025-11-23 11:12:38As of 21 November 2025, the valuation grade for GoodRx Holdings, Inc. has moved from attractive to very attractive. Despite this positive change, the company appears to be overvalued based on its current P/E ratio of 38, which is significantly higher than the peer average of approximately 31.76 for similar companies. Additionally, the EV to EBITDA ratio stands at 9.64, indicating a premium compared to some peers, while the Price to Book Value is 2.23, suggesting that the market is pricing the stock at a higher value relative to its book value. When compared to its peers, GoodRx's valuation ratios indicate a disparity, particularly against PropertyGuru Group Ltd. and ZipRecruiter, Inc., which have P/E ratios of -132.05 and -12.45, respectively. This context highlights that GoodRx's valuation may not be justified given its performance metrics, such as a ROE of 5.92% and a ROCE of 11.40%. Furthermore, the com...
Read full news article
GoodRx Holdings Hits 52-Week Low at $3.21 Amidst Significant Decline
2025-11-05 16:53:33GoodRx Holdings, Inc. has hit a new 52-week low, reflecting a significant decline over the past year. Despite this downturn, the company reported positive financial metrics, including strong operating cash flow and net profit. Institutional investors maintain a substantial stake, indicating confidence in its fundamentals.
Read full news article
GoodRx Holdings Hits 52-Week Low at $3.25 Amid Significant Decline
2025-11-04 18:04:29GoodRx Holdings, Inc. has reached a new 52-week low, reflecting a significant decline over the past year. Despite this downturn, the company reported strong financial metrics, including high operating cash flow and net profit. GoodRx also has a substantial market capitalization and high institutional ownership, indicating investor confidence.
Read full news article





